Symbols

AKRO(Delisted)

Akero Therapeutics·NASDAQ

--(--)

AKRO fundamentals

AKRO Q2 2019 Earnings

Akero Therapeutics (AKRO) released its earnings on Aug 12, 2019: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), missed estimates.

Revenue / YoY

EPS / YoY

Report date

Aug 12, 2019

Earnings

EPS

Revenue

Revenue & Expenses

Key Indicators

Akero Therapeutics (AKRO) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Akero Therapeutics (AKRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Akero Therapeutics (AKRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Akero Therapeutics (AKRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Akero Therapeutics (AKRO) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Akero Therapeutics (AKRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data